Abstract
The gut microbiota is a complex ecosystem that has a symbiotic relationship with its host. An association between the gut microbiota and disease was first postulated in the early 20th century. However, until the 1990s, knowledge of the gut microbiota was limited because bacteriological culture was the only technique available to characterize its composition. Only a fraction (estimated at <30%) of the gut microbiota has been cultured to date. Since the 1990s, advances in culture-independent techniques have spearheaded our knowledge of the complexity of this ecosystem. These techniques have elucidated the microbial diversity of the gut microbiota and have shown that alterations in the gut microbiota composition and function are associated with certain disease states, such as IBD and obesity. These new techniques are fast, facilitate high throughput, identify organisms that are uncultured to date and enable enumeration of organisms present in the gut microbiota. This Review discusses the techniques that can used to characterize the gut microbiota, when they can be applied to human studies and their relative advantages and limitations.
Key Points
-
A fraction estimated at <30% of the gut microbiota has been cultured to date; new culture-independent techniques have been developed that have revolutionized our knowledge of the gut microbiota
-
The majority of these techniques are based on the extraction of DNA and amplification of 16S ribosomal RNA genes
-
16S rRNA genes are highly conserved between bacterial species, but vary in a manner that allows species identification
-
Different techniques can phylogenetically identify and/or quantify the components of the gut microbiota
-
Metagenomics is the most recent development in the study of the gut microbiota and is defined as the study of collective genomes from the environment
-
Metagenomics will further expand our knowledge of the association between the gut microbiota and disease, and help identify causative mechanisms
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Savage, D. C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31, 107–133 (1977).
Steinhoff, U. Who controls the crowd? New findings and old questions about the intestinal microflora. Immunol. Lett. 99, 12–16 (2005).
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
O'Hara, A. M. & Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 7, 688–693 (2006).
Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 (2006).
Hooper, L. V., Bry, L., Falk, P. G. & Gordon, J. I. Host–microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 20, 336–343 (1998).
Neish, A. S. Microbes in gastrointestinal health and disease. Gastroenterology 136, 65–80 (2009).
Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915–1920 (2005).
Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635–1638 (2005).
Tap, J. et al. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574–2584 (2009).
Metchnikoff, E. & Mitchell, P. C. The prolongation of life; optimistic studies (W. Heinemann, London; G. P. Putnam's Sons, New York, 1907).
Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).
Dear, K. L., Elia, M. & Hunter, J. O. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig. Dis. Sci. 50, 758–766 (2005).
Huycke, M. M. & Gaskins, H. R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. (Maywood) 229, 586–597 (2004).
Brady, L. J., Gallaher, D. D. & Busta, F. F. The role of probiotic cultures in the prevention of colon cancer. J. Nutr. 130, 410S–414S (2000).
Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005).
Scott, F. W. Food-induced type 1 diabetes in the BB rat. Diabetes Metab. Rev. 12, 341–359 (1996).
Vrieze, A. et al. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53, 606–613 (2010).
Manichanh, C. et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205–211 (2006).
Rajilic-Stojanovic, M., Smidt, H. & de Vos, W. M. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 9, 2125–2136 (2007).
Zoetendal, E. G., Vaughan, E. E. & de Vos, W. M. A microbial world within us. Mol. Microbiol. 59, 1639–1650 (2006).
Marchesi, J. R. Human distal gut microbiome. Environ. Microbiol. 13, 3088–3102 (2011).
Zoetendal, E. G. et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68, 3401–3407 (2002).
Carroll, I. M. et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G799–G807 (2011).
Barbara, G. et al. The immune system in irritable bowel syndrome. J. Neurogastroenterol. Motil. 17, 349–359 (2011).
Claesson, M. J. et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS ONE 4, e6669 (2009).
Guarner, F. & Malagelada, J. R. Gut flora in health and disease. Lancet 361, 512–519 (2003).
Zengler, K. et al. Cultivating the uncultured. Proc. Natl Acad. Sci. USA 99, 15681–15686 (2002).
Ingham, C. J. et al. The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganisms. Proc. Natl Acad. Sci. USA 104, 18217–18222 (2007).
Stams, A. J. Metabolic interactions between anaerobic bacteria in methanogenic environments. Antonie Van Leeuwenhoek 66, 271–294 (1994).
Rajendhran, J. & Gunasekaran, P. Microbial phylogeny and diversity: small subunit ribosomal RNA sequence analysis and beyond. Microbiol. Res. 166, 99–110 (2011).
Clarridge, J. E. 3rd. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin. Microbiol. Rev. 17, 840–862 (2004).
Olsen, G. J., Lane, D. J., Giovannoni, S. J., Pace, N. R. & Stahl, D. A. Microbial ecology and evolution: a ribosomal RNA approach. Annu. Rev. Microbiol. 40, 337–365 (1986).
von Wintzingerode, F., Gobel, U. B. & Stackebrandt, E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol. Rev. 21, 213–229 (1997).
Carey, C. M., Kirk, J. L., Ojha, S. & Kostrzynska, M. Current and future uses of real-time polymerase chain reaction and microarrays in the study of intestinal microbiota, and probiotic use and effectiveness. Can. J. Microbiol. 53, 537–550 (2007).
Mariat, D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123 (2009).
Bartosch, S., Fite, A., Macfarlane, G. T. & McMurdo, M. E. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70, 3575–3581 (2004).
Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183–1189 (2009).
Rinttila, T., Kassinen, A., Malinen, E., Krogius, L. & Palva, A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 97, 1166–1177 (2004).
Ponnusamy, K., Choi, J. N., Kim, J., Lee, S. Y. & Lee, C. H. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J. Med. Microbiol. 60, 817–827 (2011).
Zwielehner, J. et al. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp. Gerontol. 44, 440–446 (2009).
Jalanka-Tuovinen, J. et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 6, e23035 (2011).
Sekirov, I., Russell, S. L., Antunes, L. C. & Finlay, B. B. Gut microbiota in health and disease. Physiol. Rev. 90, 859–904 (2010).
Muyzer, G., de Waal, E. C. & Uitterlinden, A. G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59, 695–700 (1993).
Noor, S. O. et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 10, 134 (2010).
Muyzer, G. DGGE/TGGE a method for identifying genes from natural ecosystems. Curr. Opin. Microbiol. 2, 317–322 (1999).
Zoetendal, E. G., Akkermans, A. D. & De Vos, W. M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64, 3854–9 (1998).
Osborn, A. M., Moore, E. R. & Timmis, K. N. An evaluation of terminal-restriction fragment length polymorphism (T-RFLP) analysis for the study of microbial community structure and dynamics. Environ. Microbiol. 2, 39–50 (2000).
Marsh, T. L. Terminal restriction fragment length polymorphism (T-RFLP): an emerging method for characterizing diversity among homologous populations of amplification products. Curr. Opin. Microbiol. 2, 323–327 (1999).
McCartney, A. L. Application of molecular biological methods for studying probiotics and the gut flora. Br. J. Nutr. 88 (Suppl. 1), S29–S37 (2002).
Li, F., Hullar, M. A. & Lampe, J. W. Optimization of terminal restriction fragment polymorphism (TRFLP) analysis of human gut microbiota. J. Microbiol. Methods 68, 303–311 (2007).
Hayashi, H., Sakamoto, M., Kitahara, M. & Benno, Y. Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol. Immunol. 47, 557–570 (2003).
Matsumoto, M., Sakamoto, M., Hayashi, H. & Benno, Y. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J. Microbiol. Methods 61, 305–319 (2005).
Amann, R. I. et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl. Environ. Microbiol. 56, 1919–25 (1990).
Rigottier-Gois, L., Bourhis, A. G., Gramet, G., Rochet, V. & Dore, J. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol. Ecol. 43, 237–245 (2003).
Zoetendal, E. G. et al. Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl. Environ. Microbiol. 68, 4225–4232 (2002).
Moter, A. & Gobel, U. B. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J. Microbiol. Methods 41, 85–112 (2000).
Nadal, I., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56, 1669–1674 (2007).
Kleessen, B., Kroesen, A. J., Buhr, H. J. & Blaut, M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034–1041 (2002).
Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M. & Doerffel, Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 14, 147–161 (2008).
Rochet, V., Rigottier-Gois, L., Rabot, S. & Dore, J. Validation of fluorescent in situ hybridization combined with flow cytometry for assessing interindividual variation in the composition of human fecal microflora during long-term storage of samples. J. Microbiol. Methods 59, 263–270 (2004).
Palmer, C. et al. Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res. 34, e5 (2006).
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. & Brown, P. O. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177 (2007).
Paliy, O., Kenche, H., Abernathy, F. & Michail, S. High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray. Appl. Environ. Microbiol. 75, 3572–3579 (2009).
Rajilic-Stojanovic, M. et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 11, 1736–1751 (2009).
DeAngelis, K. M. et al. PCR amplification-independent methods for detection of microbial communities by the high-density microarray PhyloChip. Appl. Environ. Microbiol. 77, 6313–6322 (2011).
Rajilic-Stojanovic, M. et al. Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis. Microbiology 156, 3270–3281 (2010).
Cook, K. L. & Sayler, G. S. Environmental application of array technology: promise, problems and practicalities. Curr. Opin. Biotechnol. 14, 311–318 (2003).
Spiegelman, D., Whissell, G. & Greer, C. W. A survey of the methods for the characterization of microbial consortia and communities. Can. J. Microbiol. 51, 355–386 (2005).
Cole, J. R. et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141–D145 (2009).
Sanger, F., Nicklen, S. & Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 74, 5463–5467 (1977).
Andoh, A., Benno, Y., Kanauchi, O. & Fujiyama, Y. Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. Curr. Pharm. Des. 15, 2066–2073 (2009).
Voelkerding, K. V., Dames, S. A. & Durtschi, J. D. Next-generation sequencing: from basic research to diagnostics. Clin. Chem. 55, 641–658 (2009).
Rogers, Y. H. & Venter, J. C. Genomics: massively parallel sequencing. Nature 437, 326–327 (2005).
Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).
Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6, e280 (2008).
Jeffery, I. B. et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut http://dx.doi.org/10.1136/gutjnl-2011-301501.
Handelsman, J., Rondon, M. R., Brady, S. F., Clardy, J. & Goodman, R. M. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem. Biol. 5, R245–R249 (1998).
Peterson, J. et al. The NIH Human Microbiome Project. Genome Res. 19, 2317–2323 (2009).
Venter, J. C. et al. Environmental genome shotgun sequencing of the Sargasso Sea. Science 304, 66–74 (2004).
Breitbart, M. et al. Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 185, 6220–6223 (2003).
De Vos, W. M. Mining the microbes—the human microbiome as model. Microb. Biotechnol. 2, 153–154 (2009).
Zoetendal, E. G., Rajilic-Stojanovic, M. & de Vos, W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605–1615 (2008).
Smith, L. M. et al. Fluorescence detection in automated DNA sequence analysis. Nature 321, 674–679 (1986).
Madabhushi, R. S. Separation of 4-color DNA sequencing extension products in noncovalently coated capillaries using low viscosity polymer solutions. Electrophoresis 19, 224–230 (1998).
Ronaghi, M., Uhlen, M. & Nyren, P. A sequencing method based on real-time pyrophosphate. Science 281, 363–365 (1998).
Margulies, M. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376–380 (2005).
Acknowledgements
The authors thank Dr J. O'Callaghan, Paul O' Toole's laboratory, University College Cork, Ireland, for the microarray image in Figure 6. Microbiota studies in the authors' laboratories are funded in part by awards from Science Foundation Ireland, the Health Research Board and the (Government of Ireland) Department of Agriculture, Food and Fisheries.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to all aspects of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fraher, M., O'Toole, P. & Quigley, E. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol 9, 312–322 (2012). https://doi.org/10.1038/nrgastro.2012.44
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2012.44
This article is cited by
-
In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study
Microbiome (2024)
-
Microbiome as a biomarker and therapeutic target in pancreatic cancer
BMC Microbiology (2024)
-
Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review
Folia Microbiologica (2024)
-
Gut microbiota in patients with kidney stones: a systematic review and meta-analysis
BMC Microbiology (2023)
-
‘Multi-omics’ data integration: applications in probiotics studies
npj Science of Food (2023)